Revolution Medicines shared Phase III clinical trial results for a pill called daraxonrasib in patients with previously ...

For people at high risk of breast cancer, timely and accurate screening can be lifesaving, helping doctors to find cancer ...

Ben knew better than to confront his dad, a retired neuroscientist who bristled at anyone questioning his intellectual ...

SCLC, addressing a high-relapse setting with limited second-line efficacy and modest survival benefit. Ifinatamab deruxtecan ...

Pharmaceutical giant Pfizer has abandoned negotiations to have a breakthrough cancer drug listed on the Pharmaceutical ...

Paclitaxel remains first-line for cutaneous angiosarcoma, but absence of validated second-line therapy creates a major unmet ...

A novel targeted therapy, daraxonrasib, has demonstrated a meaningful improvement in overall survival for patients with ...

Mt. Vernon Baptist Church is hosting a colorectal cancer health forum aimed at raising awareness and encouraging early ...

Mary Bird Perkins Cancer Center in Baton Rouge, Louisiana is offering a CAR-T cell-based immunotherapy, which genetically ...

SAN JUAN, PUERTO RICO -- A novel regimen for platinum-resistant ovarian cancer solidified its role as a treatment option with ...

Surgery and Radiation: Common effects include swelling (lymphedema), skin irritation similar to a sunburn and fatigue.

Portland scientists at Oregon Health & Science University say they have figured out why pancreatic tumors so often brush off ...